Fevipiprant
|
|
|
- CAS-Nr.
- 872365-14-5
- Englisch Name:
- Fevipiprant
- Synonyma:
- QAW039;CS-2449;NVP-QAW039;Fevipipran;Fevipiprant;NVP-QAW039;QAW039;Fevipiprant (QAW039);Fevipiprant(NVP-QAW039);Fevipiprant, 10 mM in DMSO;NVP-QAW039; QAW039;QAW039;QAW-039;QAW 039;FEVIPIPRANT
- CBNumber:
- CB13054555
- Summenformel:
- C19H17F3N2O4S
- Molgewicht:
- 426.41
- MOL-Datei:
- 872365-14-5.mol
|
Fevipiprant Eigenschaften
- Siedepunkt:
- 637.6±55.0 °C(Predicted)
- Dichte
- 1.44±0.1 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- L?slichkeit
- DMF: 10 mg/mL; DMF:PBS(pH7.2) (1:2): 0.33 mg/mL; DMSO: 10 mg/mL; Ethanol: 1 mg/mL
- Aggregatzustand
- A crystalline solid
- pka
- 3.33±0.30(Predicted)
- Farbe
- White to off-white
- InChI
- InChI=1S/C19H17F3N2O4S/c1-11-15(9-17(25)26)14-4-3-7-23-18(14)24(11)10-12-5-6-13(29(2,27)28)8-16(12)19(20,21)22/h3-8H,9-10H2,1-2H3,(H,25,26)
- InChIKey
- GFPPXZDRVCSVNR-UHFFFAOYSA-N
- SMILES
- C12N(CC3=CC=C(S(C)(=O)=O)C=C3C(F)(F)F)C(C)=C(CC(O)=O)C1=CC=CN=2
Fevipiprant Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Fevipiprant is used in the oral treatment of asthma and has been successful in targeting severe eosinophilic asthma.Fevipiprant is a novel oral prostaglandin D2 receptor 2 (DP2; known as CRTh2) antagonist and currently in development for the treatment of severe asthma and atopic dermatitis.
Fevipiprant Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Fevipiprant Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 117)Lieferanten
- Fevipiprant
- Fevipipran
- NVP-QAW039
- Fevipiprant(NVP-QAW039)
- QAW039
- Fevipiprant (QAW039)
- 2-Methyl-1-[[4-(methylsulfonyl)-2-(trifluoromethyl)phenyl]methyl]-1H-pyrrolo[2,3-b]pyridine-3-acetic acid
- NVP-QAW039; NVP-QAW 039; NVP-QAW-039 QAW-039; QAW039; QAW 039; FEVIPIPRANT
- CS-2449
- NVP-QAW039; QAW039;QAW039;QAW-039;QAW 039;FEVIPIPRANT
- NVP-QAW039;QAW039
- 1H-Pyrrolo[2,3-b]pyridine-3-acetic acid, 2-methyl-1-[[4-(methylsulfonyl)-2-(trifluoromethyl)phenyl]methyl]-
- 2-[2-methyl-1-[[4-methylsulfonyl-2-(trifluoromethyl)phenyl]methyl]pyrrolo[2,3-b]pyridine-3-yl]acetic acid
- Fevipiprant, 10 mM in DMSO
- 872365-14-5
